- Download as Adobe PDF
Rights statement: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is
properly cited.
Final published version, 1.23 MB, PDF document
Licence: Creative Commons: Attribution (CC-BY)
| Original language | English |
|---|
| Pages (from-to) | 301-310 |
|---|
| Journal | Veterinary and Comparative Oncology |
|---|
| Volume | 16 |
|---|
| Issue number | 3 |
|---|
| Early online date | 12 Jun 2018 |
|---|
| DOIs | |
|---|
| Publication status | Published - Sep 2018 |
|---|
Bacterial infection following cancer chemotherapy-induced neutropenia is a serious cause of morbidity and mortality in human and veterinary patients. Antimicrobial prophylaxis is contro-versial in the human oncology field, as any decreased incidence in bacterial infections is countered by patient adverse effects and increased antimicrobial resistance. Comprehensive
guidelines exist to aid human oncologists in prescribing antimicrobial prophylaxis but similar recommendations are not available in veterinary literature. As the veterinarian's role in antimi-crobial stewardship is increasingly emphasized, it is vital that veterinary oncologists implement appropriate antimicrobial use. By considering the available human and veterinary literature we
present an overview of current clinical practices and are able to suggest recommendations for prophylactic antimicrobial use in veterinary cancer chemotherapy patients.
- antimicrobial prophylaxis, antimicrobial stewardship, antineoplastic agents, neutropenia, veterinary oncology, veterinary practice guidelines as topic
ID: 59042846
